Does TALQUETAMAB-TGVS Cause Decreased appetite? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Decreased appetite have been filed in association with TALQUETAMAB-TGVS. This represents 3.6% of all adverse event reports for TALQUETAMAB-TGVS.
30
Reports of Decreased appetite with TALQUETAMAB-TGVS
3.6%
of all TALQUETAMAB-TGVS reports
2
Deaths
8
Hospitalizations
How Dangerous Is Decreased appetite From TALQUETAMAB-TGVS?
Of the 30 reports, 2 (6.7%) resulted in death, 8 (26.7%) required hospitalization, and 1 (3.3%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TALQUETAMAB-TGVS. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does TALQUETAMAB-TGVS Cause?
Cytokine release syndrome (162)
Ageusia (88)
Weight decreased (74)
Dysgeusia (73)
Skin exfoliation (65)
Immune effector cell-associated neurotoxicity syndrome (55)
Dry mouth (53)
Off label use (51)
Rash (48)
Onychomadesis (46)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which TALQUETAMAB-TGVS Alternatives Have Lower Decreased appetite Risk?
TALQUETAMAB-TGVS vs TAMIFLU
TALQUETAMAB-TGVS vs TAMOXIFEN
TALQUETAMAB-TGVS vs TAMSULOSIN
TALQUETAMAB-TGVS vs TAPENTADOL
TALQUETAMAB-TGVS vs TAPINAROF